AnaptysBio, Inc. (ANAB)
48.48
+0.25
(+0.52%)
USD |
NASDAQ |
Dec 31, 16:00
48.00
-0.48
(-0.99%)
Pre-Market: 08:13
AnaptysBio Research and Development Expense (TTM): 152.43M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 100.10M |
| Ovid Therapeutics, Inc. | 24.66M |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| CorMedix, Inc. | 12.46M |
| Verastem, Inc. | 103.74M |